Literature DB >> 15817852

Association between dietary factors and plasma adiponectin concentrations in men.

Tobias Pischon1, Cynthia J Girman, Nader Rifai, Gokhan S Hotamisligil, Eric B Rimm.   

Abstract

BACKGROUND: Adiponectin, an adipocyte-derived peptide, improves insulin sensitivity, has antiinflammatory and antiatherogenic effects, and is associated with a lower risk of ischemic heart disease (IHD) and type 2 diabetes. However, little is known about dietary predictors of plasma adiponectin concentrations in humans.
OBJECTIVE: Our objective was to examine cross-sectionally the association between dietary factors and plasma adiponectin in men.
DESIGN: Our study included 532 male participants of the Health Professionals Follow-Up Study who were selected as control subjects for an investigation of biological predictors of IHD. Diet, lifestyle, and anthropometric data were assessed by questionnaires.
RESULTS: After multivariable adjustment, adiponectin was significantly inversely related to glycemic load (-1.3 mg/L per 1-SD increase; P = 0.02) and tended to be positively associated with total fat intake (0.7 mg/L per 0.5% of energy from fat instead of carbohydrates; P = 0.06). We also found a significant nonlinear association between plasma adiponectin concentrations and alcohol intake (P for quadratic trend = 0.01). Thus, whereas nondrinkers had mean plasma adiponectin concentrations of 16.48 mg/L, those who consumed 0.1-4.9, 5.0-14.9, 15.0-29.9, or >/=30 g alcohol/d had mean concentrations of 16.79 (P = 0.77 compared with nondrinkers), 18.97 (P = 0.02), 19.11 (P = 0.01), and 18.39 (P = 0.10) mg/L, respectively.
CONCLUSIONS: Moderate alcohol intake is associated with higher adiponectin concentrations, whereas a carbohydrate-rich diet with a high glycemic load is associated with lower adiponectin concentrations in men with no history of cardiovascular disease. Although the strength of these associations was modest, our observations highlight the hypothesis that dietary factors may modulate plasma adiponectin concentrations-a potential mediator related to a reduced IHD risk.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817852     DOI: 10.1093/ajcn/81.4.780

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  38 in total

1.  Isotemporal substitution paradigm for physical activity epidemiology and weight change.

Authors:  Rania A Mekary; Walter C Willett; Frank B Hu; Eric L Ding
Journal:  Am J Epidemiol       Date:  2009-07-07       Impact factor: 4.897

Review 2.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

3.  Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome.

Authors:  Lewis H Kuller; Gregory Grandits; Jerome D Cohen; James D Neaton; Ronald Prineas
Journal:  Atherosclerosis       Date:  2006-10-02       Impact factor: 5.162

4.  Ethnic Variations in Adiponectin Levels and Its Association with Age, Gender, Body Composition and Diet: Differences Between Iranians, Indians and Europeans Living in Australia.

Authors:  Majid Meshkini; Fariba Alaei-Shahmiri; Cyril Mamotte; Jaya Dantas
Journal:  J Immigr Minor Health       Date:  2018-12

5.  The Role of Circulating Adiponectin and SNP276G>T at ADIPOQ Gene in BRCA-mutant Women.

Authors:  Antonella Daniele; Angelo Virgilio Paradiso; Rosa Divella; Maria Digennaro; Margherita Patruno; Stefania Tommasi; Brunella Pilato; Antonio Tufaro; Michele Barone; Carla Minoia; Donatella Colangelo; Eufemia Savino; Porzia Casamassima; Eleonora Bruno; Andreina Oliverio; Patrizia Pasanisi
Journal:  Cancer Genomics Proteomics       Date:  2020 May-Jun       Impact factor: 4.069

Review 6.  Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.

Authors:  Takashi Kadowaki; Toshimasa Yamauchi; Naoto Kubota; Kazuo Hara; Kohjiro Ueki; Kazuyuki Tobe
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

7.  Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice.

Authors:  Min You; Robert V Considine; Teresa C Leone; Daniel P Kelly; David W Crabb
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

8.  Serum adiponectin levels and lifestyle factors in Japanese men.

Authors:  Kazuhiko Kotani; Naoki Sakane; Kyoko Saiga; Masahiko Kato; Katsunori Ishida; Yosuke Kato; Youichi Kurozawa
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

Review 9.  Adiponectin in insulin resistance: lessons from translational research.

Authors:  Florencia Ziemke; Christos S Mantzoros
Journal:  Am J Clin Nutr       Date:  2009-11-11       Impact factor: 7.045

10.  Is adiponectin associated with acute myocardial infarction in Iranian non obese patients?

Authors:  Mohammad Shojaie; Abdoreza Sotoodah; Ghafar Shafaie
Journal:  Lipids Health Dis       Date:  2009-05-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.